Congressional lawmakers have included a provision in the Senate's interim spending legislation that postpones the implementation of a comprehensive federal prohibition on hemp-derived THC products. This legislative maneuver provides temporary relief to the hemp industry and manufacturers facing regulatory uncertainty. The delay offers stakeholders additional time to navigate the evolving regulatory landscape surrounding hemp-based cannabinoid products, which have experienced significant market growth in recent years despite federal scrutiny.

Summary auto-generated by AI from the original publisher's content. Editorial standards.